Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies
出版年份 2019 全文链接
标题
Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 8, Issue 4, Pages 554
出版商
MDPI AG
发表日期
2019-04-25
DOI
10.3390/jcm8040554
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
- (2019) Renato D. Lopes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis
- (2018) In-Soo Kim et al. Journal of Cardiology
- Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
- (2018) Raghavendra Charan P. Makam et al. PLoS One
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
- (2017) Tomas Forslund et al. EUROPACE
- Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials
- (2017) George Ntaios et al. International Journal of Stroke
- Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
- (2017) Lindsay G.S. Bengtson et al. Journal of Cardiology
- Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin
- (2017) W. C. Y. Lau et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
- (2017) Myung-Jin Cha et al. STROKE
- Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
- (2017) Ying Bai et al. STROKE
- Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice
- (2017) Steve Deitelzweig et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2017) Peter Brønnum Nielsen et al. BMJ-British Medical Journal
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
- (2017) José A López-López et al. BMJ-British Medical Journal
- Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2017) Peter Brønnum Nielsen et al. BMJ-British Medical Journal
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
- (2017) José A López-López et al. BMJ-British Medical Journal
- Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
- (2017) Gboyega Adeboyeje et al. Journal of Managed Care & Specialty Pharmacy
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation
- (2016) Pak-Hei Chan et al. HEART RHYTHM
- ‘Real-world’ haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand
- (2016) Prasad S. Nishtala et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation
- (2016) Yi-Hsin Chan et al. STROKE
- Dabigatran use in elderly patients with atrial fibrillation
- (2016) Meytal Avgil-Tsadok et al. THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban: can we trust the evidence?
- (2016) Deborah Cohen BMJ-British Medical Journal
- Rivaroxaban: can we trust the evidence?
- (2016) Deborah Cohen BMJ-British Medical Journal
- Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
- (2016) Eri Toda Kato et al. Journal of the American Heart Association
- Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous ThromboembolismCLINICAL PERSPECTIVE
- (2015) Manuj Sharma et al. CIRCULATION
- Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K AntagonistsCLINICAL PERSPECTIVES
- (2015) Géric Maura et al. CIRCULATION
- Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation
- (2015) Katsiaryna Bykov et al. THROMBOSIS AND HAEMOSTASIS
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Effectiveness and Safety of Dabigatran and Warfarin in Real-World US Patients With Non-Valvular Atrial Fibrillation: A Retrospective Cohort Study
- (2015) J. C. Lauffenburger et al. Journal of the American Heart Association
- Risk of Bleeding With Dabigatran in Atrial Fibrillation
- (2015) Inmaculada Hernandez et al. JAMA Internal Medicine
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
- (2014) Jonathan L. Halperin et al. CIRCULATION
- Dabigatran: how the drug company withheld important analyses
- (2014) D. Cohen BMJ-British Medical Journal
- Epidemiology of atrial fibrillation: European perspective
- (2014) Massimo Zoni-Berisso et al. Clinical Epidemiology
- Optimal International Normalized Ratio for Atrial Fibrillation in Asians and Japanese
- (2013) Kang-Ling Wang et al. CIRCULATION JOURNAL
- Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers
- (2013) Lisa Hartling et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009
- (2012) A. C. E. Scowcroft et al. HEART
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started